Skip to main content
Caplight Logo









Nusano

Nusano

Private
West Valley City, UtahHealthcare & Life Scienceshttps://nusano.com/

Last Round

Series C

Oct 1, 2024

Est. Valuation

$208.31M

Total Funding Raised

$265.65M

Company Overview

Nusano is a medical technology company that develops advanced ion sources and linear accelerators to enhance radioisotope manufacturing for medical and industrial applications.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Advanced Materials, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

radioisotope productionmedical radioisotopesisotope manufacturingradiopharmaceuticalsLutetium-177Actinium-225linear acceleratorradioligand therapyparticle accelerationnuclear medicinetheranosticsdomestic supply chainindustrial radioisotopesisotope supplierradiochemistry servicesstable isotope enrichment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nusano Comparables

Compare Nusano with similar companies based on industry and business-model similarity.

Nusano comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NorthStar Medical Radioisotopes, LLC
84%
Niowave Inc.
83%
SHINE Technologies
83%

Nusano Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 1, 2024
Series BNov 1, 2022
Series BSep 8, 2021
SeedOct 24, 2018
SeedOct 23, 2017

Key People

Founding team and executive leadership

Chris Lowe

Chief Executive Officer

Executive Team

Kevin Haehl

Chief Product Officer

Executive Team

Nusano Investors

Notable investors and investment history

Nusano investors
InvestorRounds
S32Series C
BrightEdgeSeries C, Series B
Wasatch Equity PartnersSeries B, Series C
BrightEdgeSeries B
Wasatch Venture PartnersSeries C
Casdin CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 11, 2025

    Received 'Best Companies to Work For' Award from Utah Business.

  • Nov 12, 2025

    Team members attended the Utah Life Sciences Summit on November 12, 2025.

Recent news

Latest coverage and updates

  • signs_new_clientSep 15, 2026

    Nusano signed new client DOE on Sep 14th '26.

Nusano Filings

Explore SEC and related filing metadata, where available.

Nusano filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersWest Valley City, Utah
Employee Range145
Year Founded2016
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?